Skip to main content

Table 5 Spearman rho correlations

From: Edema-like symptoms are common in ultra-distance cyclists and driven by overdrinking, use of analgesics and female sex – a study of 919 athletes

  Ride distance [km] Ride duration [d] Daily distance [km/d] Sex (f = 1, m = 2) BMI [kg/m2] Electrolyte intake (no = 0, yes = 1) Fluid intake [L/d] Drinking strategy Analgesic intake (no = 0, yes = 1)
ambient much thirst
Swelling Symptoms (total) .06
[−.02, .14]
.06
[−.02, .14]
−.03
[−.11, .06]
−.22***
[−.29, .13]
.06
[−.02, .14]
−.02
[−.11, .08]
−.02
[−.10, .06]
−.07
[−.15, .92]
.11**
[.03, .19]
−.05
[−.14, .04]
.20***
[.12, .28]
Facial Swelling .09*
[.01, .17]
.09*
[−.00, .17]
−.02
[−.10, .07]
−.21***
[−.30, −.12]
−.11**
[−.19, −.03]
−0.03
[−.12, .05]
.01
[−.08, .10]
−.01
[−.08, .07]
.04
[−.04, .11]
−.02
[−.09, .07]
.11**
[.02, .18]
Eyelid Swelling .08*
[.01, .16]
.07(*)
[−.01, .16]
.01
[−.07, .08]
−.18***
[−.27, .08]
−.11*
[−.19, −.04]
.02
[−.06, .10]
−.02
[−.10, .05]
.02
[−.07, .10]
.07(*)
[−.00, .15]
−.05
[−.13, .03]
.10*
[.02, .18]
Swelling of toes/feet .04
[−.04, .11]
.02
[−.06, .10]
.01
[−.07, .08]
−.06
[−.14, .03]
.05
[−.03, .12]
.01
[−.08, .09]
−.00
[−.07, .08]
−.05
[−.13, .03]
.08*
[.01, .17]
−.05
[−.14, .03]
.18***
[.10, .25]
Swelling of fingers/hands −.03
[−.11, .05]
−.02
[−.10, .06]
−.02
[−.11, .06]
−.14**
[−.22, .06]
.08*
[.00, .15]
−.06
[−.14, .03]
−.00
[−.09, .07]
−.09*
[−.17, −.01]
.12*
[.04, .20]
−.03
[−.11, .05]
.12*
[.04, .20]
Swelling of extremities .05
[−.04, .13]
.05
[−.04, .12]
−.03
[−.11, .05]
−.13*
[−.22, .04]
−.03
[−.10, .05]
−.02
[−.10, .06]
−.01
[−.08, .07]
−.05
[−.14, .02]
.07(*)
[−.01, .16]
−.04
[−.12, .04]
.12*
[.04, .20]
Reduced urine output −.16***
[−.23, −.07]
−.12**
[−.19, −.04]
−.02
[−.09, .07]
−.06
[−.14, .02]
−.00
[−.09, .08]
.04
[−.04, .13]
.01
[−.07, .09]
−.03
[−.11, .05]
.05
[−.03, .13]
.03
[−.04, .12]
.01
[−.07, .09]
Increased urine output .09*
[.01, .18]
.08*
[−.00, .16]
−.00
[−.08, .08]
−.03
[−.11, .06]
−.06
[−.14, .01]
.05
[−.03, .11]
.05
[−.03, .13]
−.00
[−.08, .08]
−.01
[−.08, .07]
−.07
[−.15, .01]
.02
[−.05, .10]
Concentrated/darker urine −.12**
[−.21, −.04]
−.10*
[−.17, −.02]
−.01
[−.09, .06]
.03
[−.10, .12]
.08*
[−.00, .16]
.07
[−.03, .16]
−.05
[−.13, .03]
−.13**
[−.21, −.05]
.04
[−.04, .12]
.08(*)
[−.01, .16]
−.01
[− 10, .06]
Less concentrated/lighter urine .02
[−.06, .09]
.01
[−.07, .09]
.01
[−.08, .10]
−.02
[−.10, .06]
−.04
[−.12, .05]
−.03
[−.11, .05]
.09*
[.02, .17]
.01
[−.07, .09]
.03
[−.05, .11]
−.07(*)
[−.14, .01]
.02
[−.06, .10]
Bubbly/Foamy urine −.01
[−.09, .08]
−.02
[−.10, .06]
.01
[−.07, .09]
.02
[−.06, .08]
−.03
[−.11, .06]
.05
[−.02, .09]
−.03
[−.12, .04]
−.05
[−.14, .03]
−.03
[−.11, .05]
.06
[−.03, .15]
.04
[−.04, .13]
  1. Parentheses indicate 95% confidence intervals. Levels of significance: (*): marginal significance p < .10, *: p < 0.05, **: p < 0.01, ***: p < 0.001. Abbreviations: body mass index (BMI)